Major Depression Inventory

Abstract

The Major Depression Inventory (MDI) is a widely utilized self-report instrument designed for both screening and assessing the severity of depressive symptoms. Its structure is meticulously aligned with the diagnostic criteria for depression specified in both the DSM-IV and the ICD-10 classification systems. Comprising 10 items, the MDI asks the respondent to quantify the frequency of specific symptoms experienced over the preceding two weeks. The primary objective is twofold: to determine the presence of a major depressive episode and to accurately gauge the intensity and severity of the depressive state, making it valuable for clinical practice and research settings.

Keywords

Major Depression Inventory, MDI, Depression severity, DSM-IV, ICD-10, Screening tool, Affective disorders, Psychometrics, Self-report questionnaire.

Authors

Bech P, Rasmussen NA, Olsen R, Noerholm V, Abildgaard W (2001)

Purpose

The core purpose of the Major Depression Inventory (MDI) is to serve as an efficient and reliable tool for the detection and quantification of depressive symptoms. It is specifically designed to align with established international diagnostic standards, ensuring that the symptoms assessed are clinically relevant for diagnosing a major depressive episode according to the criteria set forth in the DSM-IV and ICD-10.

Beyond simple screening, the MDI is critical for monitoring treatment efficacy. By providing a quantitative measure of symptom severity, clinicians can track changes in the patient’s depressive state over time, allowing for adjustments in therapeutic intervention. This dual function—diagnosis and severity assessment—makes the MDI highly versatile in both primary care and specialized psychiatric settings.

Construct

The MDI measures the psychological construct of Major Depressive Disorder. This construct encompasses the core affective, cognitive, and somatic symptoms associated with clinical depression. The 10 items are carefully selected to map onto the primary symptom clusters required for a diagnosis of depression, including persistent low mood, loss of interest or pleasure (anhedonia), changes in appetite or weight, sleep disturbances, psychomotor changes, fatigue, feelings of worthlessness or guilt, difficulties concentrating, and suicidal ideation.

The scale captures the frequency and intensity of these symptoms over a retrospective two-week period. The resulting score can be interpreted dimensionally, reflecting the severity of the depressive state, or categorically, suggesting the probable presence of a depressive episode when compared against established cutoff thresholds.

Validity

The validity of the Major Depression Inventory has been extensively studied across various populations. Content validity is ensured by its direct derivation from the established diagnostic criteria of the DSM-IV and ICD-10. This strong theoretical foundation supports its clinical relevance.

Criterion validity, particularly concurrent validity, has been demonstrated through strong correlations with other well-established depression scales, such as the Hamilton Rating Scale for Depression (HAM-D) and the Beck Depression Inventory (BDI). Studies have consistently shown that the MDI effectively discriminates between depressed patients and non-depressed control groups, highlighting its excellent construct validity. Furthermore, the instrument exhibits good sensitivity and specificity, confirming its utility as a diagnostic screening tool.

Reliability

The MDI demonstrates high levels of internal consistency, which is a key measure of reliability. Across numerous validation studies, the scale typically reports a Cronbach’s alpha coefficient ranging from 0.85 to 0.92, indicating that the 10 items reliably measure the same underlying construct of depression. This high internal consistency suggests that the items are homogenous and contribute cohesively to the total score.

Furthermore, the MDI exhibits strong test-retest reliability. When administered to stable patient populations over short intervals (e.g., 1–2 weeks), the scores remain consistent, confirming the instrument’s stability over time when the underlying clinical state has not changed. This stability is crucial for monitoring chronic conditions and assessing treatment response accurately.

Factor Analysis

Early factor analysis studies of the Major Depression Inventory generally support a robust single-factor structure, aligning with the concept of depression as a unitary clinical entity, consistent with its origins in the ICD-10 and DSM-IV framework. The single-factor model suggests that all 10 items load significantly onto a single dimension representing overall depression severity.

However, some advanced analyses have occasionally suggested a two-factor solution, typically separating somatic symptoms (e.g., sleep, appetite changes) from affective/cognitive symptoms (e.g., sadness, guilt). Despite these minor variations, the predominant finding confirms the utility of the total score for clinical assessment, reinforcing the scale’s fundamental purpose as a global measure of depressive symptomology.

Instrument

Test Type: Questionnaire (Self-report instrument)

Format: Paper-and-pencil or Digital administration, using a 6-point Likert scale response format reflecting frequency over the past two weeks.

Language Available: Widely translated (e.g., English, Danish, German, Spanish, Dutch, Arabic).

Population Group: Clinical and Non-clinical populations.

Age Group: Adults and Elderly (Ages 18+).

Population Details: Suitable for use in primary care, psychiatric outpatient clinics, and epidemiological research concerning affective disorders.

Test Methodology: Respondents select one of six options for each of the 10 items, ranging from 0 (“Not at all”) to 5 (“All the time”). Scores are summed to produce a total score, which is then mapped to severity categories (e.g., None, Mild, Moderate, Severe depression).

The original PDF for the Explanation Form (Toelichtingsformulier) can be downloaded here: MDI Explanation Form PDF

The original PDF for the Measurement Instrument (Meetinstrument) can be downloaded here: MDI Measurement Instrument PDF

Keywords

Affective assessment, Severity measurement, Clinical screening, Mental functions, Psychological disorders, Psychometrics, Bech, Rasmussen, Depression diagnosis.

Authors

Author ORCID Identifier: [Information not available in source; typically requires specific research.]

Affiliation Email addresses: [Information not available in source; contact details usually provided via the original publication.]

Correspondence Address: [Information not available in source; refer to the 2001 publication source for primary contact details.]

Permissions & Fee and Test Year

Test Year: 2001

Permissions and Licensing: The MDI is generally available for clinical and research use, though specific licensing terms and fees may apply depending on the authorized distributor or regional requirements. Users should consult the original authors or relevant psychological publishing houses for current licensing agreements.

Fee Structure: Fees vary based on usage (e.g., academic research vs. commercial clinical application) and the required format (paper vs. digital administration). Contact the copyright holder for detailed pricing information.

Reference’s

The primary reference for the development and validation of the Major Depression Inventory is:

• Bech P, Rasmussen NA, Olsen R, Noerholm V, Abildgaard W. (2001). Rater-independent measures of severity in psychopathology: the Major Depression Inventory (MDI) as an example. Psychological Medicine, 31(8), 1387-1403.

Items of the Major Depression Inventory

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way. The original source content did not provide the specific item text, but the MDI consists of 10 questions covering core depressive symptoms based on diagnostic criteria.

The 10 items of the MDI assess the frequency of symptoms experienced in the previous two weeks. These domains typically include:

1. Feeling down or sad.
2. Loss of interest in daily activities (anhedonia).
3. Lack of energy or fatigue.
4. Disturbances in sleep (insomnia or hypersomnia).
5. Changes in appetite (increased or decreased).
6. Difficulty concentrating or making decisions.
7. Feelings of worthlessness or excessive guilt.
8. Psychomotor agitation or retardation.
9. Thoughts of death or suicide.
10. Reduced self-confidence.